NICE (UK National Institute for Clinical Excellence) details ninth wave appraisals, new process ahead
This article was originally published in Clinica
The UK's National Institute for Clinical Excellence (NICE) has announced the final details of its ninth wave of technology appraisals. These include guidance on the management of diabetes in pregnancy (due for publication in July 2006); urinary tract infection in children (July 2007); atrial fibrillation (September 2007); prostate cancer (publication date to be confirmed); and breast cancer (tbc).
You may also be interested in...
Europe's largest online pharmacy is calling for online sales of OTC medicines to be allowed in its home market Switzerland, to increase the supply of crucial products to help people manage the symptoms of COVID-19, such as headaches, fever, diarrhoea, coughs, colds or nausea.
Confusion is rife over low UK testing levels to confirm COVID-19 in health care staff and patients, and comparisons with measures taken in similar-sized economies have been unfavorable. Diagnostics manufacturers are not to blame, says the industry.
Novartis's Jakavi joins the likes of Roche's Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients.